Ambit Biosciences Company
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2000
Employees Number:
51-100
Funding Status:
M&A
Investors Number:
15
Total Funding:
215727869 USD
Estimated Revenue:
$10M to $50M
Last Funding Date:
2012-11-06
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership